Tandem Melphalan and Autolog. SCT in MM Patients 60 to 70 Years of Age With and Without Induction Chemotherapy
Collection of Transplant Stem Cells for Plasma Cell Myeloma
Th1/Tc1 Immunotherapy Following Stem Cell Transplantation in Multiple Myeloma
VELCADEXA: Velcade and Dexamethasone in Multiple Myeloma
Melphalan, Prednisone, Thalidomide and Defibrotide in Relapsed Multiple Myeloma Patients
Busulfan and Melphalan Conditioning in Multiple Myeloma
Velcade-Melphalan-Prednisone in Older Untreated Multiple Myeloma Patients.
† Indicates status has not been verified in more than two years